We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Antihypertensive Medications and Breast Cancer Risk

Justine Hugon-Rodin, MD1; Anne Gompel, MD, PhD1; Geneviève Plu-Bureau, MD, PhD1
[+] Author Affiliations
1Department of Gynecology and Endocrinology, Hôpital Universitaire Paris Centre, Paris-Descartes University, Paris, France
JAMA Intern Med. 2014;174(4):640-641. doi:10.1001/jamainternmed.2013.13752.
Text Size: A A A
Published online


To the Editor In their article, Li and colleagues1 assess the association between antihypertensive medication use and increased breast cancer risk in women aged 55 to 74 years. They conclude that only continued use of calcium channel blockers for 10 years or more was significantly associated with a higher risk of breast cancer. However, we query the lack of significant results in their study concerning β-blocker use and breast cancer risk. The potential effect of β-blocker use on the risk of cancer is an important issue, and we believe that the results deserve to be reported stratified by β-adrenergic receptor (AR) antagonist subtype.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





April 1, 2014
Christopher I. Li, MD, PhD; Mei-Tzu C. Tang, PhD; Kathleen E. Malone, PhD
1Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
JAMA Intern Med. 2014;174(4):641. doi:10.1001/jamainternmed.2013.13740.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...